M. Oroszlán

Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway.

B. Meier, P. Mohacsi, H. Marti, 2010, Transplant immunology.

Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis.

T. Carrel, P. Mohacsi, M. Oroszlán, 2011, Transplantation proceedings.

Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP.

I. Gombos, M. Daha, L. Romics, 2006, International immunology.

Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway.

C. Zuppinger, P. Mohacsi, M. Oroszlán, 2009, Molecular immunology.

Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability.

P. Mohacsi, M. Oroszlán, M. Bieri, 2009, The international journal of biochemistry & cell biology.

Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins1

M. Daha, G. Arlaud, U. Kishore, 2005, The Journal of Immunology.

Collectins C 1 qProteoglycans Decorin and Biglycan with Interactions of the Extracellular Matrix

M. Daha, G. Arlaud, U. Kishore, 2005 .

Proliferation signal inhibitor-induced decrease of vascular endothelial cadherin expression and increase of endothelial permeability in vitro are prevented by an anti-oxidant.

B. Meier, P. Mohacsi, S. Koestner, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

MBL and C1q compete for interaction with human endothelial cells.

M. Daha, Z. Prohászka, G. Füst, 2007, Molecular immunology.

Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors

G. Kéri, L. Őrfi, D. Erős, 2009, Journal of receptor and signal transduction research.

Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.

L. Romics, Z. Prohászka, G. Füst, 2002, Immunology letters.

Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis.

P. Mohacsi, M. Oroszlán, B. Baur, 2011, Transplantation proceedings.